Tumor determination in bowel cancer: Blood test replaces surgery
One of the challenges of personalised medicine is the development of treatment resistance. At the Comprehensive Cancer Center (CCC) Vienna at the MedUni Vienna and Vienna General Hospital, a study is now commencing which involves patients with metastasized bowel cancer who are undergoing a new diagnostic method, namely liquid biopsy in the form of a blood test. The aim of this new method is to spot a tumor’s development of resistance early on and therefore adjust the treatment quickly and in a targeted manner…